Efficacy of Capecitabine Metronomic Chemotherapy to Triple-negative Breast Cancer
Clinical trial NCT01112826 · COMPLETED
Trial details
- NCT number
- NCT01112826
- Sponsor
- Sun Yat-sen University
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-04-23
- Primary completion
- 2019-12-31
- Enrollment
- 443
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.